4//SEC Filing
Nuss John 4
Accession 0001415889-24-028996
CIK 0001851194other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:21 PM ET
Size
18.2 KB
Accession
0001415889-24-028996
Insider Transaction Report
Form 4
Nuss John
CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-12-10$0.20/sh+193,557$38,711→ 463,932 total - Exercise/Conversion
Stock Option (right to buy)
2024-12-10−5,377→ 0 totalExercise: $0.20Exp: 2030-05-01→ Common Stock (5,377 underlying) - Exercise/Conversion
Common Stock
2024-12-10$0.20/sh+5,377$1,075→ 270,375 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-10−193,557→ 0 totalExercise: $0.20Exp: 2029-03-27→ Common Stock (193,557 underlying)
Footnotes (2)
- [F1]Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 1, 2020.
- [F2]Option granted under pursuant to the Issuer's 2019 Plan. Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 6, 2019.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001874108
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:21 PM ET
- Size
- 18.2 KB